A clinical case of Zellweger syndrome in a patient with a previous history of ocular medulloepithelioma
- PMID: 30224891
- PMCID: PMC6137698
- DOI: 10.1016/j.sjopt.2017.09.004
A clinical case of Zellweger syndrome in a patient with a previous history of ocular medulloepithelioma
Abstract
Peroxisomal biogenesis disorders (PBDs) are autosomal recessive diseases caused by mutations in one of the 14 PEX genes described in the scientific literature. All of these syndromes may be associated with different mutations in the PEX genes, the most frequent being PEX1 for patients with Zellweger syndrome (ZS). In this paper, we present the case of a patient with a peculiar clinical history: evisceration of the left eye (LE) at 4 years of age because of a benign ocular teratoid medulloepithelioma and a progressive loss of visual acuity (VA) in the right eye (RE) beginning at 9 years of age, leading to the diagnosis of ZS. In addition, the patient presented a mutation in the PEX14 gene that has not been previously described in the literature. This case broadens the spectrum of clinical expression in ZS patients because of not only the presence of a benign ocular teratoid medulloepithelioma at 4 years of age but also the late clinical expression of ZS (at 9 years of age).
Keywords: Leukodystrophy; Ocular medulloepithelioma; Optic neuropathy; Zellweger syndrome.
Figures



Similar articles
-
Compound heterozygous p. Arg949Trp and p. Gly970Ala mutations deteriorated the function of PEX1p: A study on PEX1 in a patient with Zellweger syndrome.J Cell Biochem. 2021 May 6. doi: 10.1002/jcb.29945. Online ahead of print. J Cell Biochem. 2021. PMID: 33955040
-
Mild form of Zellweger Spectrum Disorders (ZSD) due to variants in PEX1: Detailed clinical investigation in a 9-years-old female.Mol Genet Metab Rep. 2020 Jun 20;24:100615. doi: 10.1016/j.ymgmr.2020.100615. eCollection 2020 Sep. Mol Genet Metab Rep. 2020. PMID: 32596134 Free PMC article.
-
A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype.Hum Genet. 1999 Jul-Aug;105(1-2):38-44. doi: 10.1007/s004399900095. Hum Genet. 1999. PMID: 10480353
-
PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders.Hum Mutat. 2005 Sep;26(3):167-75. doi: 10.1002/humu.20211. Hum Mutat. 2005. PMID: 16086329 Review.
-
History of the cerebrohepatorenal syndrome of Zellweger and other peroxisomal disorders.South Med J. 1988 Mar;81(3):357-64. doi: 10.1097/00007611-198803000-00017. South Med J. 1988. PMID: 2450404 Review.
Cited by
-
Allogeneic Hematopoietic Stem Cell Transplantation for PEX1-Related Zellweger Spectrum Disorder: A Case Report and Literature Review.Front Pediatr. 2021 Aug 25;9:672187. doi: 10.3389/fped.2021.672187. eCollection 2021. Front Pediatr. 2021. PMID: 34513757 Free PMC article.
References
-
- Waterham H.R., Ebberink M.S. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochem Biophys Acta. 2012 Sep;1822(9):1430–1441. - PubMed
-
- Steinberg S.J., Raymond G.V., Braverman N.E., Moser A.B. Peroxisome biogenesis disorders, zellweger syndrome spectrum. In: Pagon R.A., Adam M.P., Ardinger H.H., Wallace S.E., Amemiya A., Bean L.J.H., Bird T.D., editors. GeneReviews® [Internet] University of Washington, Seattle; Seattle (WA): 2003. 1993–2015.
-
- Wanders R.J., Klouwer F.C., Ferdinandusse S., Waterham H.R., Poll-Thé B.T. Clinical and laboratory diagnosis of peroxisomal disorders. Methods Mol Biol. 2017;1595:329–342. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources